{"id":"W3099865510","doi":"10.1016/j.hlc.2020.09.491","title":"484 Effect of Longer-Term Administration of Evolocumab in Patients With Angiographic Coronary Artery Disease: Results of the GLAGOV Open Label Extension Study","year":2020,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Evolocumab; Discontinuation; Medicine; Placebo; Adverse effect; Interquartile range; Internal medicine; Clinical endpoint; Statin; Cardiology; Incidence (geometry); Clinical trial; Cholesterol; Apolipoprotein B","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001224678,0.0008896196,0.002141942,0.000210989,0.0003011215,0.001084739,0.0004550234,0.001117033,0.002973794],"category_scores_gemma":[0.001692554,0.0003282173,0.002495998,0.000286285,0.0005333834,0.00102978,0.0002711425,0.002680829,0.0006228948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000523078,"about_ca_system_score_gemma":0.000454512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008191667,"about_ca_topic_score_gemma":0.001225523,"domain_scores_codex":[0.9994246,0.0002542611,0.00003173934,0.0001018753,0.00005240598,0.0001352151],"domain_scores_gemma":[0.9990187,0.0003119869,0.0002105677,0.0001208048,0.00005792378,0.0002801405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9032463,0.007627936,0.01078474,0.0003833,0.00207518,0.0001472376,0.0001286134,0.0006967973,0.00712756,0.00009155534,0.0007564429,0.06693423],"study_design_scores_gemma":[0.4383642,0.3451574,0.2022302,0.0001539743,0.00488365,0.0003019384,0.00019693,0.001701991,0.002608185,0.0003757343,0.003883256,0.0001424519],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961869,0.002361742,0.0000921055,0.0001376707,0.00008238979,0.00006386761,0.0003313647,0.00001798424,0.0007259595],"genre_scores_gemma":[0.9962716,0.00114055,0.0001932894,0.0003189978,0.0001790882,0.00008831999,0.0006377657,0.00001139786,0.001158996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002973794,"threshold_uncertainty_score":0.009948313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01441679133978791,"score_gpt":0.2669190966390055,"score_spread":0.2525023052992176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}